Anand Devaraj

“These findings add to the growing evidence that quantitative CT can provide important information about structural lung disease that may be complementary to conventional measures such as FVC. In this analysis of patients with PPF, quantitative CT measurements were associated with subsequent disease progression and were sensitive to the effects of antifibrotic treatment. The findings support the continued development and incorporation of quantitative CT as an objective biomarker for clinical trials and, potentially, for monitoring disease progression in clinical practice.”